Lin-Spek
Oral Solution Powder
Lin-Spek contains Lincomycin from Lincosamide group and Spectinomycin from Aminoglycosides group.
Composition:
150 g medication contains Lincomycin HCl equivalent to 33.3 g Lincomycin and Spectinomycin sulfate tetrahydrate equivalent to 66.7 g Spectinomycin base.
Indications:
In broiler hens and turkeys, used for the treatment of chronic upper respiratory tract infections (CRD) and CRD complexes, synovitis, cholera, E. coli and Salmonella infections (Colibacillosis, paratyphoid), Staphylococcus spp. infections, necrotic enteritis (especially C. perfringens), Sacculitis and Arizona infection of turkey poults caused by Mycoplasma.
Dose of Administration:
Unless recommended otherwise by the Veterinarian;
Pharmacological dose:
In poultry50 mg/kg b.w./day.
Practical dose:
In poultry, 150 g/day Lin-Spek for 2000 kg body weight is added to the daily tap water.
Treatment period is 3-7 days. The doses described above are daily doses and should be added to the tap water that will be consumed in 24 hours, and normal fresh water should not be administered until the completion of medicated water administration.
Drug Residue Withdrawal Period (D.R.W.P):
Hens should not be sent to slaughter during treatment or until 3 days after the last administration, and turkeys should not be sent to slaughter during treatment or until 8 days after the last drug administration. It should not be administered to poultry their eggs of which are presented for human consumption.
Packaging Type:
Presented in unboxed 0.15, 0.5, 1 and 2.5 kg plastic jars closed with aluminum foils.